Close Icon We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies.

Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Products:

Pharma Consulting

Conferences 2020

Awards

Upcoming Webinars

Webinar recordings

Close Icon

Global Search Configuration

Search Site Products & Services
Close Icon

Search by Keyword

Focus
Needs

Tailor-made Pharma Solutions

Make better informed business decisions with customized pharmaceutical consulting and marketing services that give you the edge over your competition.

Tailor-made solutions

Use the expertise and experience of Pharma Intelligence to produce custom solutions that are actionable, flexible, and tailored to help you successfully navigate biopharma portfolio management, commercial optimization, and R&D strategy. Benefit from:

A customized approach – we develop solutions to fit your situation
Joint problem/opportunity definition
Proprietary data and complementary market research
The experience of 500+ industry experts
Collaborative problem solving
Fact-based decisions and actionable recommendations
Ownership of final decisions and action plans

Discover new business opportunities, reduce risks, and make better, faster decisions with tailor-made pharmaceutical solutions from Pharma Intelligence.

Skipta

The Impact of Covid-19 on B2B Marketers

When circumstances make meeting in person an impossibility, Skipta Gather is there. Don’t miss out on reaching your target audience because travel is curtailed and meetings are cancelled. Use Skipta Gather to conduct virtual sessions with verified physicians and get the job done.

Topic Advertising, Marketing & Sales

View infographic
Datamonitor Healthcare, Biomedtracker

COVID-19 and the impact on the clinical trial space

The effect of COVID-19 on clinical trials, the industry response, and the return to full operations

Topic Coronavirus Clinical Trials

View white paper
Awareness, Pharma Consulting

Hunting for Cancer Neoantigens : What is the best approach?

Important insights into neoantigen-based immunotherapies and which developers are leading in this growing area.

Topic Cancer Clinical Trial Optimization

View white paper
Scrip

Pfizer CEO Bourla Wants Profit From COVID-19 Vaccine

Several countries already are calling about orders, as the company prepares to begin a Phase III trial of its mRNA coronavirus vaccine candidate.

Topic Coronavirus Vaccines

View article
Scrip

Gilead Sets Remdesivir Price Commits Nearly All Near-Term Supplies To US

A five-day course will cost $2,340 for governments in developed countries and $3,120 for commercial payers. The US will get 100% of remdesivir manufactured by Gilead in July.

Topic Coronavirus

View article
Citeline, Datamonitor Healthcare

COVID-19 24-hour web event: Lessons learned and a path forward

Join our free 24-hour interactive webinar series on 21 July that will cover the latest insights and learning on COVID-19 from across the global Pharma and Biomedtech industry.

Topic Coronavirus

View interactive data
HBW Insight

Health, Beauty and Wellness Coronavirus Coverage

The COVID-19 pandemic has impacted the consumer health and beauty products industries in different ways, and HBW Insight covers it all. We deliver all the latest regulatory, legislative, legal and commercial developments across the over-the-counter medicine, dietary supplement and the cosmetics sectors to keep you informed and strategically on target.

Topic Coronavirus

Single report
Pink Sheet

New Leader & Reorgs at Key Regulatory Agencies

Pink Sheet invites you to go inside the recent personnel changes at key regulatory agencies around the globe – including US FDA, EMA, and England’s NICE – and how these new appointments will likely influence future regulation of the biopharma industry.

Topic Regulation

Single report
Scrip

Seizing The Day: How Coronavirus Breaks Then Makes Vaccine Makers In China

Amid fears of a second wave of coronavirus infections and the increasing dominance of state-owned enterprises, private vaccine makers in China are struggling to make the best of the outbreak, BravoVax CEO Ke Wu tells Scrip in an exclusive interview.

Topic Coronavirus Vaccines Clinical Trials

View article
Scrip

CanSino Claims Lead In COVID-19 Vaccine Race And Takes Swipe At Moderna's Ethics

Vaccines veteran calls Moderna ‘shabby’ for lack of transparency and shares sell-off, and flags CanSino’s own forthcoming Phase II results.

Topic Coronavirus Clinical Trials Vaccines

View article
Medtech Insight

Senate Bills Would Require More COVID-19 PPE, US Manufacturing Capacity, Use Of Analytical Imaging

Legislators at a 23 June Senate health panel hearing exploring prevention of future pandemics similar to COVID-19 discussed legislation they have recently introduced to resolve the current viral crisis.

Topic Coronavirus Legislation

View article
Medtech Insight

Diagnostics Industry In Spotlight As Germany Doubles Down To Prevent Second COVID-19 Wave

Germany’s authorities are back on guard against COVID-19 following renewed regional outbreaks. Diagnostics manufacturers will continue to play a strong part in bringing the pandemic substantially under control, a recent industry association virtual conference heard.

Topic Coronavirus Policy & Regulation

View article
Generics Bulletin

Glenmark Debuts Favipiravir For COVID-19 In India

Glenmark has received the go-ahead in India for and launched its low-priced favipiravir product for mild to moderate COVID-19 under an accelerated approval process.

Topic Coronavirus Drug Review

View article
HBW Insight

US COVID-19 Fraud: Licorice Promoted As Treatment, Unapproved Tests Offered OTC

FDA and FTC continue adding to total each has made during novel coronavirus pandemic. FTC's latest include peroxide gel and licorice as treatments; FDA’s emphasizes in warnings that three businesses' tests were not approved for OTC sales or for home use.

Topic Coronavirus Dietary Supplements

View article
Pink Sheet

Patient-Reported Data In COVID-Impacted Trials: US FDA Cautions Against Missing Data, Potential Bias

Considerations for switching from in-person to remote collection of patient- and observer-reported outcomes addressed in latest update to Q&A guidance, which also discusses Part 11 compliance requirements in the context of the pandemic and electronic collection of informed consent through MyStudies app.

Topic Coronavirus Clinical Trials

View article